Cinacalcet for secondary hyperparathyroidism in end-stage renal disease patients below age 5 years 
.

CONCLUSION: Cinacalcet can be effectively used in young children on dialysis with minimal side effects. Good linear growth was seen in patients on cinacalcet and GH therapy. Long-term large scale data is necessary to confirm. Institution-based management algorithm incorporating cinacalcet would be helpful to maintain uniformity in role of cinacalcet for management of CKD-MBD.
.
PMID: 31587754 [PubMed - as supplied by publisher]

Source: Clinical Nephrology - October 6, 2019 Category: Urology & Nephrology Authors: Joseph C, Shah S, Geer J, Juarez-Calderon M, Srivaths PR, Swartz SJ Tags: Clin Nephrol Source Type: research